$277 Million is the total value of Johnson & Johnson Innovation - JJDC, Inc.'s 11 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARWR | New | Arrowhead Pharmaceuticals, Inc. | $206,837,000 | – | 3,260,869 | +100.0% | 74.59% | – |
| PHGE | New | BiomX Inc. | $20,662,000 | – | 2,133,402 | +100.0% | 7.45% | – |
| PTGX | New | Protagonist Therapeutics, Inc. | $17,267,000 | – | 2,449,183 | +100.0% | 6.23% | – |
| PRVB | New | Provention Bio, Inc. | $16,762,000 | – | 1,124,973 | +100.0% | 6.04% | – |
| PHAS | New | PhaseBio Pharmaceuticals, Inc. | $9,819,000 | – | 1,607,044 | +100.0% | 3.54% | – |
| ALDX | New | Aldeyra Therapeutics, Inc. | $3,456,000 | – | 594,834 | +100.0% | 1.25% | – |
| CSLT | New | Castlight Health, Inc.cl b | $1,079,000 | – | 811,295 | +100.0% | 0.39% | – |
| SENS | New | Senseonics Holdings, Inc | $481,000 | – | 525,632 | +100.0% | 0.17% | – |
| CBIO | New | Catalyst Biosciences, Inc. | $456,000 | – | 66,951 | +100.0% | 0.16% | – |
| GNCA | New | Genocea Biosciences, Inc. | $298,000 | – | 143,964 | +100.0% | 0.11% | – |
| TCON | New | Tracon Pharmaceuticals, Inc. | $197,000 | – | 84,003 | +100.0% | 0.07% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. | 7 | Q2 2021 | 74.6% |
| PROTAGONIST THERAPEUTICS INC. | 7 | Q2 2021 | 11.2% |
| BIOMX INC. | 7 | Q2 2021 | 8.1% |
| PHASEBIO PHARMACEUTICALS, INC. | 7 | Q2 2021 | 3.5% |
| ALDEYRA THERAPEUTICS, INC. | 7 | Q2 2021 | 1.2% |
| CASTLIGHT HEALTH INC. | 7 | Q2 2021 | 0.4% |
| SENSEONICS HOLDINGS, INC. | 7 | Q2 2021 | 0.2% |
| CATALYST BIOSCIENCES, INC. | 7 | Q2 2021 | 0.2% |
| TRACON PHARMACEUTICALS, INC. | 7 | Q2 2021 | 0.1% |
| MEIRAGTX HOLDINGS PLC | 6 | Q2 2021 | 21.2% |
View Johnson & Johnson Innovation - JJDC, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-05-10 |
| 3 | 2024-04-10 |
| 4 | 2024-03-06 |
| 13F-NT | 2024-02-14 |
| 3/A | 2024-02-02 |
| 4/A | 2024-02-02 |
| SC 13G | 2023-11-16 |
| 13F-NT | 2023-11-09 |
| 3 | 2023-09-18 |
| 3 | 2023-09-18 |
View Johnson & Johnson Innovation - JJDC, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.